bioMérieux, Inc. and McKesson Medical-Surgical Announce Distribution Alliance

▤ Summary

The agreement highlights the two companies’ shared focus on antibiotic stewardship and preventing sepsis in hospital care settings by delivering better solutions for healthcare providers to fight infections and their often-deadly complications. Tests like VIDAS® B•R•A•H•M•S PCT™, can empower hospitals to improve antimicrobial stewardship and positively impact patient care, no matter what their size,” said Brian Armstrong, Executive Vice President & General Manager, bioMérieux, Inc. McKesson recognizes the strategic importance of laboratory services in the health care continuum, and has steadily accelerated its investment and growth in this segment over the past several years. This includes the 2016 acquisition of LABSCO, a national distributor of laboratory equipment and supplies, which expanded McKesson’s footprint in the segment. “ We’re excited to partner with bioMérieux, Inc. and help represent its industry-leading in vitro diagnostics portfolio in the community hospital market,” said Doug Shaver, Senior Vice President and General Manager, McKesson Laboratory Solutions. The company provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

▦ Linked Companies

bioMérieux

$1B+